129 related articles for article (PubMed ID: 38679705)
1. SYVN1 modulates papillary thyroid carcinoma progression by destabilizing HMGB1.
Duan F; Kong F; Jiang T; Liu H
Cell Div; 2024 Apr; 19(1):15. PubMed ID: 38679705
[TBL] [Abstract][Full Text] [Related]
2. Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis.
Ji F; Zhou M; Sun Z; Jiang Z; Zhu H; Xie Z; Ouyang X; Zhang L; Li L
Cancer Commun (Lond); 2021 Oct; 41(10):1007-1023. PubMed ID: 34196494
[TBL] [Abstract][Full Text] [Related]
3. Exogenous H
Zhang S; Wang M; Li H; Li Q; Liu N; Dong S; Zhao Y; Pang K; Huang J; Ren C; Wang Y; Tian Z; Lu F; Zhang W
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2719-2732. PubMed ID: 37899701
[TBL] [Abstract][Full Text] [Related]
4. SYVN1 attenuates ferroptosis and alleviates spinal cord ischemia-reperfusion injury in rats by regulating the HMGB1/NRF2/HO-1 axis.
Guo L; Zhang D; Ren X; Liu D
Int Immunopharmacol; 2023 Oct; 123():110802. PubMed ID: 37591122
[TBL] [Abstract][Full Text] [Related]
5. Propofol upregulates miR-320a and reduces HMGB1 by downregulating ANRIL to inhibit PTC cell malignant behaviors.
Li M; Qu L; Chen F; Zhu X
Pathol Res Pract; 2020 Apr; 216(4):152856. PubMed ID: 32098696
[TBL] [Abstract][Full Text] [Related]
6. CircRTN1 stimulates HMGB1 to regulate the malignant progression of papillary thyroid cancer by sponging miR-101-3p.
Zheng M; Xu L; Wei C; Guan W
Hormones (Athens); 2023 Jun; 22(2):281-293. PubMed ID: 36826778
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Regulator KDM4D Restricts Tumorigenesis
Yao W; Wang J; Zhu L; Jia X; Xu L; Tian X; Hu S; Wu S; Wei L
Front Oncol; 2021; 11():761346. PubMed ID: 34820329
[TBL] [Abstract][Full Text] [Related]
8. USP15 promotes the progression of papillary thyroid cancer by regulating HMGB1 stability through its deubiquitination.
Wang SS; Ye DX; Wang B; Li MY; Zhao WX
J Cancer; 2024; 15(9):2561-2572. PubMed ID: 38577597
[No Abstract] [Full Text] [Related]
9. SYVN1 ubiquitinates FoxO1 to induce β-catenin nuclear translocation, PD-L1-mediated metastasis, and immune evasion of hepatocellular carcinoma.
Xie W; Shi L; Quan H; Xiao H; Chen J; Liu J; de Dieu Habimana J; Huang R; Luo J; Chen P; Li Z
Cell Oncol (Dordr); 2023 Oct; 46(5):1285-1299. PubMed ID: 37099251
[TBL] [Abstract][Full Text] [Related]
10. VNLG-152R and its deuterated analogs potently inhibit/repress triple/quadruple negative breast cancer of diverse racial origins
Thankan RS; Thomas E; Purushottamachar P; Weber DJ; Ramamurthy VP; Huang W; Kane MA; Njar VCO
Front Oncol; 2023; 13():1240996. PubMed ID: 37766871
[TBL] [Abstract][Full Text] [Related]
11. Synoviolin inhibits the inflammatory cytokine secretion of Müller cells by reducing NLRP3.
Zhang J; Chen C; Wu L; Wang Q; Chen J; Zhang S; Chen Z
J Mol Endocrinol; 2022 Jan; 68(2):125-136. PubMed ID: 34874278
[TBL] [Abstract][Full Text] [Related]
12. Tumor‑suppressive effects of Smad‑ubiquitination regulator 2 in papillary thyroid carcinoma.
Luo G; Zhang L; Zhang L; Wu W; Lin J; Shi H; Yu Y; Qiu W; Chen J; Ding H; Chen X
Oncol Lett; 2024 Jun; 27(6):263. PubMed ID: 38646500
[TBL] [Abstract][Full Text] [Related]
13. SYVN1-mediated ubiquitination and degradation of MSH3 promotes the apoptosis of lens epithelial cells.
Chen X; Zhang G; Li P; Yu J; Kang L; Qin B; Wang Y; Wu J; Wang Y; Zhang J; Qin M; Guan H
FEBS J; 2022 Sep; 289(18):5682-5696. PubMed ID: 35334159
[TBL] [Abstract][Full Text] [Related]
14. circ_0067934 promotes the progression of papillary thyroid carcinoma cells through miR-1301-3p/HMGB1 axis.
Dong LP; Chen LY; Bai B; Qi XF; Liu JN; Qin S
Neoplasma; 2022 Jan; 69(1):1-15. PubMed ID: 34704451
[TBL] [Abstract][Full Text] [Related]
15. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
17. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circRNA-0039459 promotes the migration, invasion, and proliferation of liver cancer cells through the adsorption of miR-432.
Zhou W; Yang F
Bioengineered; 2022 May; 13(5):11810-11821. PubMed ID: 35543347
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC00704 promotes cell proliferation, migration, and invasion in papillary thyroid carcinoma via miR-204-5p/HMGB1 axis.
Lin Y; Jiang J
Open Life Sci; 2020; 15(1):561-571. PubMed ID: 33817244
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of synoviolin in peripheral blood from obese/overweight donors.
Fujita H; Aratani S; Mizoguchi I; Yagishita N; Nakajima T
Exp Ther Med; 2020 Nov; 20(5):121. PubMed ID: 33005247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
